Market Place
Sourcing Support
TScan Therapeutics to Present at 25th Annual Needham Healthcare
08 Apr 2026 //
GLOBENEWSWIRE
TScan Therapeutics Reports Q4/FY 2025 Results and Business Update
04 Mar 2026 //
GLOBENEWSWIRE
TScan Therapeutics Completes Phase 1 ALLOHA Cohort C Enrollment
26 Feb 2026 //
GLOBENEWSWIRE
TScan Therapeutics to Join TD Cowen 46th Annual Health Care
25 Feb 2026 //
GLOBENEWSWIRE
Tscan Therapeutics Reveals Positive ALLOHA Phase 1 Heme Trial
06 Dec 2025 //
GLOBENEWSWIRE
Tscan Therapeutics Hosts Virtual KOL Event On ALLOHA Phase 1
03 Dec 2025 //
GLOBENEWSWIRE
Tscan Therapeutics Reports Q3 2025 Financials & Corporate
13 Nov 2025 //
GLOBENEWSWIRE
Tscan Therapeutics Joins Guggenheim Healthcare Innovation
05 Nov 2025 //
GLOBENEWSWIRE
Tscan Lays Off 30% Of Workforce, Halts Solid Tumor TCR Trial
03 Nov 2025 //
FIERCE BIOTECH
TScan Therapeutics to Present at ACR Convergence 2025
17 Sep 2025 //
GLOBENEWSWIRE
TScan Therapeutics to Present at Investor Conferences
03 Sep 2025 //
GLOBENEWSWIRE
TScan Therapeutics Q2 2025 Financial Results and Corporate Update
12 Aug 2025 //
GLOBENEWSWIRE
TScan Therapeutics to Present at Jefferies Global Healthcare Conf
28 May 2025 //
GLOBENEWSWIRE
TScan Therapeutics to Present at ASGCT 28th Annual Meeting
28 Apr 2025 //
GLOBENEWSWIRE
TScan Therapeutics at 24th Annual Needham Virtual Healthcare Conf
31 Mar 2025 //
GLOBENEWSWIRE
TScan Therapeutics Names Stephen Camiolo Senior VP, Market Access
27 Mar 2025 //
GLOBENEWSWIRE
TScan Therapeutics Reports Q4 & Full Year 2024 Financial Results
05 Mar 2025 //
GLOBENEWSWIRE
TScan Therapeutics to Present at TD Cowen 45th Annual Health Care
27 Feb 2025 //
GLOBENEWSWIRE
TScan to Participate in 3rd Annual Cell Therapy Virtual Conference
18 Feb 2025 //
GLOBENEWSWIRE
TScan Therapeutics Announces $30M Offering at 37% Premium
26 Dec 2024 //
GLOBENEWSWIRE
TScan Therapeutics Presents Updated ALLOHA™ Trial Data at ASH 2024
09 Dec 2024 //
GLOBENEWSWIRE
TScan Therapeutics Reports Q3 2024 Financial Results & Update
12 Nov 2024 //
GLOBENEWSWIRE
TScan Therapeutics Presents Data from ALLOHA™ Phase 1 Trial
05 Nov 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces Presentations At SITC Annual Meet
04 Oct 2024 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in Upcoming Investor Conferences
29 Aug 2024 //
GLOBENEWSWIRE
TScan Therapeutics Reports Q2 2024 Results And Corporate Update
12 Aug 2024 //
GLOBENEWSWIRE
Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics
06 Jul 2023 //
BUSINESSWIRE
TScan Therapeutics Announces Closing of Public Offering
01 Jun 2023 //
PRESS RELEASE
TScan Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
10 Apr 2023 //
GLOBENEWSWIRE
